The Fluocinolone Acetonide Market serves three primary end-use settings: hospitals, clinics, and home care, each contributing uniquely to overall market dynamics. Hospitals represent a critical channel, particularly for severe or acute cases requiring specialist intervention, intravitreal injections, or combination therapies administered under medical supervision. Hospital-based usage is...